VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $439,596,000 | -9.3% | 4,324,602 | +59.2% | 3.61% | -11.8% |
| Q3 2015 | $484,617,000 | -26.2% | 2,716,768 | -8.1% | 4.10% | -20.8% |
| Q2 2015 | $656,580,000 | +8.6% | 2,955,571 | -2.9% | 5.17% | +1.6% |
| Q1 2015 | $604,507,000 | +8.2% | 3,043,537 | -22.0% | 5.09% | -2.0% |
| Q4 2014 | $558,463,000 | +14.9% | 3,902,332 | +5.3% | 5.19% | +3.7% |
| Q3 2014 | $486,221,000 | +3.1% | 3,705,951 | -0.9% | 5.01% | +3.7% |
| Q2 2014 | $471,419,000 | +16.5% | 3,737,861 | +21.8% | 4.83% | +4.5% |
| Q1 2014 | $404,569,000 | -1.1% | 3,068,871 | -12.0% | 4.62% | -4.6% |
| Q4 2013 | $409,186,000 | +15.5% | 3,485,400 | +2.7% | 4.85% | +2.5% |
| Q3 2013 | $354,170,000 | +22.3% | 3,394,708 | +0.9% | 4.73% | +29.5% |
| Q2 2013 | $289,536,000 | – | 3,363,568 | – | 3.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |